Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112010492 | 11201049 | 2 | F | 2015 | 20160714 | 20150619 | 20160721 | EXP | BR-AMGEN-BRASP2015059554 | AMGEN | 61.00 | YR | A | F | Y | 68.00000 | KG | 20160721 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112010492 | 11201049 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, 1X/WEEK | 94.8280029 | MG | N | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||
| 112010492 | 11201049 | 2 | C | AROVIT | 2 | UNK | 0 | ||||||||||||
| 112010492 | 11201049 | 3 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 400 MG, UNK | 0 | 400 | MG | |||||||||
| 112010492 | 11201049 | 4 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 4 MG, DAILY | 0 | 4 | MG | QD | ||||||||
| 112010492 | 11201049 | 5 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 1 DF, AT NIGHT | 0 | 1 | DF | |||||||||
| 112010492 | 11201049 | 6 | C | GLIBENCLAMIDE | GLYBURIDE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 112010492 | 11201049 | 7 | C | ANGIPRESS | ATENOLOL | 1 | 25 MG, UNK (STRENGTH 25 MG) | 0 | 25 | MG | |||||||||
| 112010492 | 11201049 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 112010492 | 11201049 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 112010492 | 11201049 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK, 1X/DAY FASTING | 0 | |||||||||||
| 112010492 | 11201049 | 11 | C | ACITRETIN. | ACITRETIN | 1 | UNK | 0 | |||||||||||
| 112010492 | 11201049 | 12 | C | TIGASON /00530101/ | 2 | UNK | 0 | ||||||||||||
| 112010492 | 11201049 | 13 | C | MIOSAN | CYCLOBENZAPRINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 112010492 | 11201049 | 14 | C | OMEGA /01454401/ | 2 | Unknown | UNK, QD | 0 | QD | ||||||||||
| 112010492 | 11201049 | 15 | C | CALCIUM | CALCIUM | 1 | UNK UNK, QD | 0 | QD | ||||||||||
| 112010492 | 11201049 | 16 | C | BEPANTOL | 2 | Unknown | UNK | 0 | |||||||||||
| 112010492 | 11201049 | 17 | C | DIPROSALIC | BETAMETHASONE DIPROPIONATE | 1 | Topical | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112010492 | 11201049 | 1 | Product used for unknown indication |
| 112010492 | 11201049 | 4 | Diabetes mellitus |
| 112010492 | 11201049 | 6 | Diabetes mellitus |
| 112010492 | 11201049 | 7 | Hypertension |
| 112010492 | 11201049 | 8 | Gastrointestinal disorder |
| 112010492 | 11201049 | 9 | Gastritis |
| 112010492 | 11201049 | 11 | Psoriasis |
| 112010492 | 11201049 | 12 | Psoriasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112010492 | 11201049 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112010492 | 11201049 | Fall | |
| 112010492 | 11201049 | Malaise | |
| 112010492 | 11201049 | Product use issue | |
| 112010492 | 11201049 | Skin disorder | |
| 112010492 | 11201049 | Upper limb fracture | |
| 112010492 | 11201049 | Wound | |
| 112010492 | 11201049 | Wound infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112010492 | 11201049 | 1 | 20150508 | 20150605 | 0 |